Dive into the World of Pharmaceuticals with Our Expert Insights.

Contribute to the Future of Pharmaceuticals! Share your expertise on innovations, research, and industry trends with our platform. Join us in advancing the dialogue on the dynamic landscape of pharmaceuticals.

Know More Contact Us

16+

Years of Experience

Overview of the Company

Navigating Excellence in Quality and Growth.

SKYMAP, founded in 2007 by Mr. Sanjay Gupta, is a family-owned pharmaceutical company on a trajectory of rapid growth. With over 500 products, we prioritize quality and timely delivery. Our WHO-cGMP Certified facility ensures compliance with stringent manufacturing practices. Committed to excellence, Skymap is a fully integrated, customer-focused pharmaceutical entity.

About Us

Our Products

We heal with the latest innovations in chiropractic.

Dry Powder Injection in Vail

Capacity: 70 Million/Annum

Liquid Injection in Ampoule

Capacity: 240 Million/Annum

Eye/Ear Drops (Three Piece)

Capacity: 60 Million/Annum

Liquid Injection in Vial

Capacity: 90 Million/Annum

Nasal Drops Vial

Capacity: 60 Million/Annum

Tablets

Capacity: 3600 Million/Annum

Capsules

Capacity: 1800 Million/Annum

360_F_102116769_8Megknwvgkv6ENd9HpJZQZPbGCTCUt4S

Ointment

Capacity: 48 Million/Annum

Lotion

Capacity: 18 Million/Annum

Liquid Oral

Capacity: 12 Million/Annum

Our Business Model

SPPL provides Out-Licensing services for the technology available with us for Emerging and SRA markets. We have capabilities pertaining to all the dosage forms available with us. Modality of Out-Licensing could be discussed case to case and project to project.

SPPL provides contract development and manufacturing organization (CDMO) provides end-to-end, fully integrated drug development and manufacturing solutions and services to pharmaceutical companies. We have full fledge R&D facility related to all available dosage forms. From the conception of idea to the launch of product and to the maintenance of product life cycle.

Explore our Production Units

Unit 1

Sterile Injectable & Ophthalmic Facility

we specialize in the production of sterile injectable medications, offering a range of essential pharmaceuticals vital for patient care. Our commitment to excellence extends to the manufacturing of Ophthalmic products, addressing critical eye care needs with precision and innovation.

With a focus on quality, safety, and efficacy, Skymap Pharmaceuticals’ Unit 1 is dedicated to advancing healthcare through the production of sterile injectables and ophthalmic solutions, contributing to the well-being of patients worldwide.

Capacity in Million/Annum

Nasal Drops Vial

Eye/Ear Drops (Three Piece)

Liquid Injection in Vial

Nasal Drops Vial

Liquid Oral

Dry Powder Injection in Vail

Liquid Injection in Ampoule

Eye/Ear Drops (Three Piece)

Dry Powder Injection in Vail

Liquid Injection in Ampoule

Liquid Injection in
Vial

Capacity in Million/Annum

Capsules

Liquid Oral

Tablets

Ointment

Unit 2

OSD, Oral Liquid, External Preparation & Cephalosporins Facility

Skymap Pharmaceuticals proudly operates Unit 2, a state-of-the-art production plant dedicated to the manufacturing of Oral Solid Dosage (OSD) and Cephalosporins. As a leading pharmaceutical facility, we specialize in producing high-quality medications that adhere to the highest industry standards. Our cutting-edge infrastructure and advanced technology enable us to deliver innovative and reliable pharmaceutical solutions.

Unit 2

OSD, Oral Liquid, External Preparation & Cephalosporins Facility

Capacity in Million/Annum

Tablets

Liquid Oral

Capsules

Ointment

Upcoming plant in J&K

OSD, CEPHALOSPORINS, PENICILLINS & CARBAPENEMS.

In line with our commitment to innovation and expansion, we are thrilled to announce the upcoming establishment of a cutting-edge facility in Jammu and Kashmir. This facility will be specifically designed to cater to our esteemed partners, featuring a dedicated block for the production of OSD, Cephalosporins, Penicillins, and Carbapenems. By leveraging the latest technologies and adhering to stringent quality control measures, we aim to bolster our capabilities and further contribute to the advancement of healthcare.